CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 48 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 4.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,726,154 | +4.7% | 730,472 | +0.2% | 0.77% | +24.5% |
| Q2 2023 | $4,512,987 | +60.8% | 729,077 | 0.0% | 0.62% | +71.5% |
| Q1 2023 | $2,806,946 | +23.4% | 729,077 | -0.7% | 0.36% | +3.7% |
| Q4 2022 | $2,275,171 | -22.6% | 733,926 | +0.3% | 0.35% | -43.7% |
| Q3 2022 | $2,941,000 | -20.3% | 731,521 | -3.5% | 0.62% | -34.3% |
| Q2 2022 | $3,691,000 | -38.5% | 757,848 | +13.3% | 0.94% | -51.6% |
| Q1 2022 | $6,002,000 | +123.0% | 669,100 | +179.9% | 1.95% | +35.3% |
| Q4 2021 | $2,692,000 | – | 239,041 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| OUP Management Co., LLC | 2,937,615 | $19,006,369 | 42.74% |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $129,161,626 | 41.24% |
| Vida Ventures Advisors, LLC | 3,931,818 | $25,438,862 | 39.38% |
| TCG Crossover Management, LLC | 2,040,816 | $13,204,079 | 1.94% |
| Affinity Asset Advisors, LLC | 1,018,091 | $6,587,049 | 1.85% |
| BVF INC/IL | 9,103,054 | $58,896,759 | 1.59% |
| Sio Capital Management, LLC | 756,891 | $4,897,085 | 1.52% |
| ACUTA CAPITAL PARTNERS, LLC | 323,349 | $2,092,068 | 1.40% |
| EcoR1 Capital, LLC | 5,618,779 | $36,353,500 | 1.23% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $62,641,362 | 0.97% |